RE-REPORTED BY
youarewithinthenorms.com
NORMAN J CLEMENT RPH., DDS, NORMAN L. CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC., SPIRIT OF REV. IN THE SPIRIT OF WALTER R. CLEMENT BS., MS, MBA. HARVEY JENKINS, MD, PH.D., IN THE SPIRIT OF C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., M.B.A., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., EVELYN J. CLEMENT, IN THE SPIRIT OF WALTER F. WRENN III., MD., JULIE KILLINGSWORTH, RENEE BLARE, RPH, DR. TERENCE SASAKI, MD LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., RICHARD KAUL, MD., IN THE SPIRIT OF LEROY BAYLOR, JAY K. JOSHI MD., MBA, AISHA GARDNER, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
This extensive article, written initially on youarewithinthenorms.com in November 2021, “IN SICKNESS AND IN HEALTH,” sharply critiques the systemic issue of structural racism. The collected texts focus heavily on the issue of structural racism and bias in the medical treatment of Black and Hispanic patients, particularly those with terminal illnesses experiencing severe pain. One source highlights a 2002 study from the Journal of the American Cancer Society detailing barriers to optimal pain management for minority cancer outpatients, along with the DEA’s intense effort to take control of the field of medicine, noting physician reluctance to prescribe opioids and inadequate pain assessment.
A 2019 New York Times article further complicates this by pointing out that racial stereotypes—such as the false belief that Black individuals are more prone to addiction or have a higher pain tolerance—unexpectedly shielded many African-Americans from fatal prescription opioid overdoses during the early crisis, yet simultaneously caused them to endure excruciating pain. While other sources criticize the actions of the Drug Enforcement Administration (DEA), arguing that the agency further criminalizes licensed pharmacists and focuses on flawed metrics, like those based on the 2016 CDC guidelines, which inhibit appropriate pain care for all patients, including a specific example of an oncologist fearing treatment due to DEA scrutiny. Overall, the documents emphasize how prejudice and misguided policy decisions perpetuate suffering and undermine ethical medical practice.
THE PERCEIVED NEEDS AND BARRIERS TO OPTIMAL CONTROL
Journal of American Cancer Society
“Cancer Pain Management Among Underserved Minority Outpatients “
2002
The year is April 2002, Karen O. Anderson, Ph.D., and her colleagues, Stephen P. Richman, M.D.Judith Hurley, M.D.Guadalupe Palos R.N., Dr.PH.Vicente Valero M.D.Tito R. Mendoza Ph.D.Ibrahima Gning D.D.S.Charles S. Cleeland, Ph.D., published in the Journal of the American Cancer Society, an article called Cancer Pain Management Among Underserved Minority Outpatients: Perceived Needs and Barriers to Optimal Control, examining the role of bias and the mindset of medical clinicians in the treatment of pain in terminally ill cancer patients, stating:
“Minority patients with cancer are at risk for undertreatment of cancer‐related pain. Most studies of patient‐related barriers to pain control have surveyed primarily non‐Hispanic Caucasian patients.
The purpose of the current study was to explore barriers to optimal pain management among African‐American and Hispanic patients with cancer through the use of structured patient interviews. Structured interviews allowed the authors to probe for previously unidentified barriers to pain management in these populations.” (1)
Most African‐American patients (93%) and all Hispanic patients stated that they discussed their cancer pain with their doctor or nurse. However, more than half of the African‐American patients (57%) and 38% of Hispanic patients indicated that their doctor or nurse did not ask about pain prior to the patient telling them about their pain.
Only 25% of African‐American patients and 29% of Hispanic patients indicated that their doctor or nurse used a pain scale for pain assessment. The pain scale was described as helpful by all patients who were asked to use one to rate their pain intensity.
Late Louis Ladson, Pharmacy Owner___
Excellent article outlining the biased attacks against black-owned independent pharmacies doing precisely what they trained to do…….” Putting patient needs first”. Just because a pharmacy does not fall within the national average norms does NOT automatically mean illegal activity is taking place… maybe exceptional pharmacy care is taking place! Too many pharmacies are being attacked w/o cause, along with assumed guilt versus assumed innocence.
Unfortunately, all of the patients indicated that they would wait until their pain was severe (≥ 7 on a 0–10 scale) before they would make a telephone call to their doctor, nurse, or oncology clinic. In addition, 88% of Hispanic patients and 82% of African‐American patients would wait until their pain intensity was a 10 before calling for assistance.
Despite the apparent gaps in communication, most Hispanic patients (86%) and African‐American patients (92%) felt that their doctor understood about their pain.
Unfortunately, 25% of African‐American patients described physician reluctance to prescribe opioid medications for their pain. Some of these patients commented that their physicians warned them about a possible addiction to pain medication.
Although no Hispanic patients reported physician reluctance to prescribe opioids, 35% of Hispanic patients were receiving analgesics that were inadequate for the severity of their pain.
When opioid analgesics were prescribed, most patients did not have difficulty obtaining them from the hospital or clinic pharmacy.
Lack of availability of a prescribed opioid in a neighborhood pharmacy was described as a barrier by 10% of the interviewed patients. The cost was described as a barrier to obtaining pain medication by another 10% of patients. Most patients, however, were able to obtain financial assistance with the costs of medication.
The African‐American patients tended to report more difficulty than the Hispanic patients discussing physical problems with other people. However, the two groups did not differ in reported difficulty with talking about having cancer or cancer‐related pain. Almost all patients in both groups stated that they discussed their pain with their physicians.
However, the majority of African‐American patients and more than one‐third of Hispanic patients indicated that they had to bring up the issue of pain management. Pain assessment reportedly was limited, with less than one‐third of patients describing some quantified measurement of their pain.
Even more disturbing was the finding that more than 80% of patients in both ethnic groups would wait until their pain severity was a 10 on a 10‐point scale before calling their health care provider or oncology clinic for assistance with pain management.
Our results revealed that many of the patients in both ethnic groups used prayer and religious beliefs as complementary strategies for coping with pain. Also, about one‐third of patients were taking nonprescription analgesics that were not recommended by their physicians or nurses. Special teas, foods, vitamins, and supplements also were reported as complementary strategies. Thus, it is important to assess carefully what nonprescription medications or supplements a patient is taking.
“One of the most troubling examples of research bias appeared on Fewer opioid prescriptions meant fewer deaths (possibly 14,000), but the episode also reveals how prevalent and harmful stereotypes can be, even if implicit.”
The provided text explores the paradoxical role of racial bias in the opioid crisis, highlighted in a 2019 New York Times article where stereotypes within the medical system led to fewer opioid prescriptions for African-Americans, inadvertently shielding them from thousands of fatal overdoses. The Times article even suggested that approximately 14,000 African-Americans were “protected” because their prescription rates were lower than those of white Americans, highlighting that these biases stemmed from false beliefs about pain tolerance and addiction risk. However, excerpts present a sharp critique of Dr. Andrew Kolodny, a prominent figure in opioid policy, accusing him of lacking subject matter expertise in pain treatment while heavily influencing federal guidelines. These critical sources allege that Dr. Kolodny’s policies, which restricted prescriptions, were completely flawed, because the ongoing overdose crisis is primarily driven by recreational drug users switching to illegal substances like fentanyl-laced heroin, not by chronic pain patients.
THE PERCEIVED NEEDS AND BARRIERS TO OPTIMAL CONTROL
THE NEW YORK TIMES
“A Rare Case Where Racial Biases’ Protected African-Americans,”
2019
It is December 5, 2019, New York Times on “A Rare Case Where Racial Biases’ Protected African-Americans,” By Austin Frakt and Toni Monkovic
When the opioid crisis began to escalate some 20 years ago, many African-Americans had a layer of protection against it.
But that protection didn’t come from the effectiveness of the American medical system. Instead, researchers believe, it came from racial stereotypes embedded within that system.
As unlikely as it may seem, these negative stereotypes appear to have shielded many African-Americans from fatal prescription opioid overdoses. This is not a new finding. But for the first time an analysis has put a number behind it, projecting that around 14,000 black Americans would have diedhad their mortality rates related to prescription opioids been equivalent to that of white Americans.
Starting in the 1990s, new prescription opioids were marketed more aggressively in white rural areas, where pain drug prescriptions were already high. African-Americans received fewer opioid prescriptions, some researchers think, because doctors believed, contrary to fact, that black people 1) were more likely to become addicted to the drugs 2) would be more likely to sell the drugs and 3) had a higher pain threshold than white people because they were biologically different.
A fourth possibility is that some white doctors were more empathetic to the pain of people who were like them, and less empathetic to those who weren’t. Some of this bias “can be unconscious,” said Dr. Andrew Kolodny, a director of opioid policy research at Brandeis University.
This accidental benefit for African-Americans is far outweighed by the long history of harm they have endured from inferior health care, including infamous episodes like the Tuskegee study. And it doesn’t remedy the way damaging stereotypes continue to influence aspects of medical practice today. “The reason to study this further is twofold,”
Dr. Kolodny said. “It’s easy to imagine the harm that could come to blacks in the future, and we need to know what went wrong with whites, and how they were left exposed” to overprescribing. The prescription opioid-related mortality rates of black and white Americans were relatively similar two decades ago, but researchers found that by 2010, the rate was two times higher for whites than for African-Americans.
Because African-Americans were less likely to receive those prescriptions, they were less likely to become addicted — though they were more likely to endure unnecessary and excruciating pain for illnesses like cancer.
__________________________________________________________/
- *According to the Eugenic Archives, ” The term ‘dehumanization’ was coined in the early 19th century and has acquired a wide range of meanings since then. These include: treating certain people in degrading ways (for instance, merely as means to an end), referring to them as non-human animals or as inanimate objects, denying that they possess distinctively human characteristics, treating them in degrading ways that cause them to experience themselves as less than human, denying that they have mental states, conceiving of other people as less human than oneself, conceiving of them as inanimate objects, and conceiving of them as subhuman animals.”
- **advocated for the 90 MME as a threshold had received up to $ 500,000.00 on one occasion (at $725 per hour) to serve as an expert witness pushing the false narrative of 90 MME’S.
THE PERCEIVED NEEDS AND BARRIERS TO OPTIMAL CONTROL
YOURWITHINTHENORMS.COM
“THE ENFORCERS OF JUNK SCIENCE AND THEIR BELIEFS”
2020
On December 22, 2020 Walmart Pharmacy writes in response to the United States Justice lawsuit stating:
“The Justice Department’s investigation is tainted by historical ethics violations, and this lawsuit invents a legal theory that unlawfully forces pharmacists to come between patients and their doctors, and is riddled with factual inaccuracies and cherry-picked documents taken out of context. Blaming pharmacists for not second-guessing the very doctors the Drug Enforcement Administration (DEA) approved to prescribe opioids is a transparent attempt to shift blame from the DEA’s well-documented failures in keeping bad doctors from prescribing opioids in the first place.
In contrast to the DEA’s own failures, Walmart always empowered our pharmacists to refuse to fill problematic opioid prescriptions, and they refused to fill hundreds of thousands of such prescriptions. Walmart sent DEA tens of thousands of investigative leads, and we blocked thousands of questionable doctors from having their opioid prescriptions filled at our pharmacies.
The Drug Enforcement Administration lacks the ability to rationalize within the agency the distinctive difference between criminal drug dealers and licensed pharmacists. This agency has charged known drug dealers and licensed pharmacists with the same federal violation 21 U.S.C. §§ 841(a)( 1) (possession with the intent to distribute and distribution of oxycodone and hydromorphone and 21 USC 846 (conspiracy to do the same) and 843 (fraud/deception regarding the same).
The multidimensional levels of corrupted behavior have allowed the DEA to view themselves as enforcers of justice in their own eyes; they see no wrong. As this agency continues on its trajectory, it will soon develop into murderous acts to protect the agency or themselves from detection.
This agency has subordinated the laws in exchange for justifying their actions. Right or wrong, they stand behind what they do and believe. This deliberate drive to be has shifted a once well-known and professional agency to accept ‘deviant, dishonest, improper, unethical, or criminal behavior. The men and women of this once-famous and respected agency would understand the impact of deception. Today, the DEA does not and cannot accept errors of its ways.
According to research done by Dr. Richard Lawhern:
“The basic premises of the 2016 CDC guidelines on the prescription of opioid analgesics to adults with chronic non-cancer pain are wrong. And CDC KNOWS they are wrong!
Higher overdose mortality from 2010-2020 is a direct outgrowth of socioeconomic factors and the invasion of illegal Fentanyl into US street markets. We also know from State-level analysis of Prescription Drug Monitoring Programs data that when a prescription-type opioid is found in postmortem toxicity screens, it is likely to be only one substance among several, including illegal or diverted drugs and alcohol. Our “drug crisis” is driven by illegal drugs, not prescriptions.”
THE PERCEIVED NEEDS AND BARRIERS TO OPTIMAL CONTROL
THE LAWHERN FILES
“WHEN AN ONCOLOGIST FEARS TREATING “CANCER”
2021
The year is 2021, March the article AN ONCOLOGIST WHO LIVES IN FEAR, publish by Richard “red” Lawhern written by Dr Shulman:
Dr. Lawhern, I have read some of your blogs. I completely agree with many of the things you stated as they apply to my particular case, where I lost my license. The reluctance of so-called “pain physicians” to care for patients who are on high doses of opioids and/or who show signs of “aberrant behavior” leaves patients suffering from pain and addiction in a precarious position and at risk for suicide. It also leaves poor physicians like me (an Oncologist) who try to provide appropriate care for patients in real pain and addiction in a terrible position.
The patient I was caring for, a middle-aged African American woman, a single parent, without adequate insurance, unfortunately committed suicide by overdosing on the opioid drugs I was supplying her. I believe that the constant fighting she experienced with the medical system, including pharmacies, doctors, and hospitals, has had a significant impact. I was trying as best I could to find a doctor with appropriate experience to care for her, but they are an extreme rarity. (2)
In her case, she was probably asking for high doses i.e. double the dose she was using, and selling some of the drugs to pay for the drugs she was using as her insurance refused to pay for her opioids. She was also doing early refills. She was seen by three pain specialists who observed aberrant behavior and either just “dropped her” or instituted or suggested rapid tapers, leaving me, a hapless oncologist, with the task of wrestling with her pain control and addiction.
https://www.c-span.org/video/?435395-3/senator-hatch-dea-opioid-crisis
Dr. Kolodny’s thinkings allow for the withholding and or the denial of medical care, based upon a preconceived racial bias, supported by a foundation of erroneous science.
The assertions and conclusions drawn by Dr. Andrew Kolodny and those who conducted this research are seriously flawed and further demonstrate how bias undermines healthcare for all Black people. These misconceptions are ingrained in people at a young age, too, according to Dore, Hoffman, Trawalter et. al., Researchers who asked black and white children to rate each other’s pain determined they’d adopted a“weak racial bias” by 7 years old and a“strong and reliable” bias by 10 years old.
Yet, more disturbingly, there has been very little push-back from Black professional medical organizations, academia, journals, and media debunking these medical stereotypes that Dr. Andrew Kolodny et al. have been promoting. The utter silence upon those who profess to represent the concerns of people of color further highlights the saying, “silence is interpreted as consent,” and“when one is not present at the table, then one is on the menu.”
DON’T GET CANCER IF YOU ARE BLACK OR HISPANIC
The barriers to pain management reported by each patient group indicate that socioeconomically disadvantaged African‐American and Hispanic patients can benefit from educational interventions on cancer pain that dispel myths about opioids and that teach patients to communicate assertively about their pain with their physicians and nurses.
In addition, some patients need education regarding realistic expectations for pain treatment. Although most patients expected pain reduction to a mild level of pain intensity, over one‐third of the total sample expected the complete elimination of pain. If this is not a realistic goal for a patient, then additional education is required.
The same is true about the War on Drugs. The efforts of the DEA, shutting down legitimate operating pharmacies, are providing drug cartels a major boost.
The arrogance of their wrong is perpetrated, with each pharmacy that is closed, the sales of illegal pain medication are increasing in the community. Such an aggressive act clearly displays that this government agency has lost its way.
It is difficult to conclude the prohibition’s impact on crime at the national level, as there were no uniform national statistics gathered about crime prior to 1930. It has been argued that organized crime received a major boost from Prohibition. (5)
FOR NOW, YOU ARE WITHIN
THE NORMS
endnotes
- https://doi.org/10.1002/cncr.10414
- https://youarewithinthenorms.com/2021/04/03/cancer-patient-pain-suicide-and-dea-policywhen-an-oncologist-fears-treating-cancer/
4. https://www.painnewsnetwork.org/stories/2021/5/12/americans-reporting-more-pain-than-ever
